SENSEX NIFTY

Glenmark Pharmaceuticals

Apr 20, 2015 at 10:49 | Source: CNBC-TV18
Ajay Bodke of Prabhudas Lilladher is positive on Glenmark Pharma and expects target price at around Rs 1186 over a one year period.
Apr 20, 2015 at 10:35 | Source: Moneycontrol.com
Based on the deal with Temasek and visibility of a superior earnings profile following US approvals and out-licensing of NCE/NBE molecules Macquarie has raised Glenmark's target price to Rs 1400 per share while maintining outperform rating.
Apr 20, 2015 at 08:54 | Source: Moneycontrol.com
Pharma sector will continue getting strong astrological support. Buy Cipla, Glenmark Pharma, Sun Pharma, Divis Lab, Ajanta Pharma, Wockhardt etc, says Satish Gupta of Astrostocktips.
Apr 17, 2015 at 23:21 | Source: Moneycontrol.com
Glenmark Pharmaceuticals has informed regarding Outcome of Board Meeting held on April 17, 2015.
Apr 17, 2015 at 20:34 | Source: CNBC-TV18
Singapore state investment arm Temasek will invest 9.45 billion rupees ($151.39 million) in Glenmark Pharmaceuticals Ltd
Apr 16, 2015 at 11:43 | Source: CNBC-TV18
Vineet Bhatnagar - MD at Phillip Capital expects 10-15 percent upside in midcap pharma stocks including Glenmark Pharma, Divis Laboratories, Torrent Pharma and Cadila Healthcare.
Apr 16, 2015 at 11:12 | Source: CNBC-TV18
Going ahead, Vineet Bhatnagar, managing director, Phillip Capital expects refinery, oil marketing companies and ONGC to show strong upward moves. He also sees another 10-15 percent upside in Glenmark, Torrent Pharma and Divis Lab.
Apr 16, 2015 at 10:30 | Source: CNBC-TV18
TS Harihar of HRBV Client Solutions is of the view that Glenmark Pharma can outperform and has a target price of Rs 1180-1200 in the next one quarter.
Apr 16, 2015 at 09:45 | Source: CNBC-TV18
Watch the interview of TS Harihar of HRBV Client Solutions with Latha Venkatesh & Sonia Shenoy on CNBC-TV18, in which he shared his readings and outlook on market and specific stocks.
Apr 15, 2015 at 15:28 | Source: CNBC-TV18
CNBC-TV18's Sonia Shenoy lists out stocks that you should focus on.
Messages on Glenmark Pharmaceuticals »

BSE/NSE Announcer

Platinum Member

7284 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding the press release dated July 08, 2014 titled,"Glenmark Generics receives final ANDA approval for Telmisartan Tablets."

12.41 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

7284 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets" Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from

12.04 PM Jul 8th 2014

phs25

Gold Member

9 Followers

Glenmark  

Glenmark Generics receives final ANDA approval for Telmisartan Tablets | 07/08/14 12:01 Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets

12.03 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

7284 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014.

11.48 AM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

7284 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has submitted to the Exchange a copy of press release dated July 03, 2014 titled "Glenmarks novel monoclonal antibody GBR 830 for treatment of autoimmune diseases entering human trials"

5.57 PM Jul 3rd 2014

BSE/NSE Announcer

Platinum Member

7284 Followers

Glenmark  

The Register of Members & Share Transfer Books of Glenmark Pharmaceuticals will remain closed from July 14, 2014 to July 25, 2014 (both days inclusive) for the purpose of Payment of Dividend & 36th Annual General Meeting (AGM) of the Company to be held on July 25, 2014.

7.05 PM Jun 30th 2014

adviserbola

Platinum Member

351 Followers

Marksans Pharma  

Did any body know Before promoting this venture Marksans Pharma, Mr. Mark Saldanha held the position of whole time Director at Glenmark Pharmaceuticals Ltd. Today Glenmark Pharma is trading above 570 Levels

10.32 PM Jun 11th 2014

Jayan C

New Member

6 Followers

Just Posted  

Glenmark Pharmaceuticals has opened its new monoclonal antibody manufacturing facility in La Chaux-de-Fonds, Switzerland.

6.22 PM Jun 5th 2014

Amrita Gaba

New Member

419 Followers

Glenmark  

Glenmark Pharmaceuticals S.A (GPSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd. has opened its new GMP compliant monoclonal antibody manufacturing facility in La Chaux-de- Fonds, Switzerland. This manufacturing facility supplements Glenmark`s existing in-house discovery

12.57 PM Jun 5th 2014

BSE/NSE Announcer

Platinum Member

7284 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated June 04, 2014, titled"Glenmark Pharmaceuticals Inaugurates new Antibody Manufacturing Facility in La Chaux-de fonds, Switzerland".

11.11 AM Jun 4th 2014

News across the web »
Apr 18, 2015 at 03:30 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.